ResMed (RMD) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Is ResMed Stock Outperforming the Nasdaq?December 17, 2024 | msn.comStifel Initiates Coverage of ResMed (RMD) with Hold RecommendationDecember 13, 2024 | msn.comResMed initiated with a Hold at StifelDecember 12, 2024 | markets.businessinsider.comResMed Inc. stock rises Wednesday, still underperforms marketDecember 11, 2024 | marketwatch.com'Huge opportunity' ahead for this ASX 200 healthcare stockDecember 10, 2024 | fool.com.auWhich insider sold $770,000 worth of ResMed shares this week?December 7, 2024 | msn.comHere's the outlook on ResMed shares in 2025December 6, 2024 | msn.comZacks Industry Outlook Highlights ResMed, Haemonetics, Phibro and AgiosDecember 5, 2024 | finance.yahoo.comInsider Activity Spotlight: Michael J Farrell Acquires In ResMed Stock OptionsNovember 28, 2024 | benzinga.comInsider Transaction: Michael J Farrell Sells $499K Worth Of ResMed SharesNovember 28, 2024 | benzinga.comResMed Inc. stock falls Wednesday, still outperforms marketNovember 27, 2024 | msn.comResMed: Solid Execution, Pricey ValuationNovember 26, 2024 | seekingalpha.comResMed Stock: Is Wall Street Bullish or Bearish?November 25, 2024 | msn.comResMed's (NYSE:RMD) earnings growth rate lags the 11% CAGR delivered to shareholdersNovember 19, 2024 | uk.finance.yahoo.comTop broker says buy ResMed and this ASX 200 shareNovember 19, 2024 | fool.com.auAfter ResMed's 60% rise, this investor is now bullish on the 'most hated' ASX stockNovember 17, 2024 | msn.comResMed’s Executive Stock Transactions Highlight Compensation PracticesNovember 13, 2024 | markets.businessinsider.comResMed Inc. CEO Executes Strategic Stock TransactionsNovember 13, 2024 | markets.businessinsider.comResMed’s Peter Farrell Adjusts Stock HoldingsNovember 13, 2024 | markets.businessinsider.comResMed Updates Dividend Details for ASX CDI HoldersNovember 12, 2024 | markets.businessinsider.comResMed Inc. Officer Plans Major Stock SaleNovember 11, 2024 | markets.businessinsider.comResMed Inc Insider Sells Shares, Retains OwnershipNovember 10, 2024 | markets.businessinsider.comResmed Inc Announces Upcoming Stock SaleNovember 10, 2024 | markets.businessinsider.comWith 74% ownership, ResMed Inc. (NYSE:RMD) boasts of strong institutional backingNovember 8, 2024 | finance.yahoo.comWant the latest ResMed dividend? Here's what you need to doNovember 1, 2024 | msn.comP/E Ratio Insights for ResMedOctober 28, 2024 | benzinga.comResMed Inc. Reports Compliance and Stock DetailsOctober 28, 2024 | msn.comMorgans Remains a Buy on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)October 28, 2024 | markets.businessinsider.comResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025October 25, 2024 | markets.businessinsider.comResMed Inc (RMD) Q1 2025 Earnings Call Highlights: Strong Financial Performance Amid Global ...October 25, 2024 | finance.yahoo.comA Peek at ResMed's Future EarningsOctober 23, 2024 | benzinga.comAnalysts Offer Insights on Healthcare Companies: Resmed (RMD) and Abbott Laboratories (ABT)October 17, 2024 | markets.businessinsider.comResmed’s Strong Performance and Optimistic Forecasts Drive Buy Rating with USD 270 TargetOctober 17, 2024 | markets.businessinsider.comResMed's Q1 2025 Earnings: What to ExpectOctober 14, 2024 | msn.comResMed Inc. stock falls Monday, still outperforms marketOctober 7, 2024 | marketwatch.comDoes ResMed (NYSE:RMD) Deserve A Spot On Your Watchlist?October 7, 2024 | finance.yahoo.comResMed projects high single-digit revenue growth until 2030October 1, 2024 | afr.com500 million reasons why ResMed shares are charging higher todayOctober 1, 2024 | msn.comBaird Initiates Coverage of ResMed (RMD) with Outperform RecommendationSeptember 25, 2024 | msn.comExpert Outlook: ResMed Through The Eyes Of 7 AnalystsSeptember 24, 2024 | benzinga.comResmed (RMD) Receives a Hold from NeedhamSeptember 18, 2024 | markets.businessinsider.comResMed slips as Wolfe downgrades on GLP-1 threat from LillySeptember 18, 2024 | msn.comVivos surges on FDA nod for pediatric sleep apnea deviceSeptember 18, 2024 | seekingalpha.comTop Stock Movers Now: US Steel, VF Corp., ResMed, and MoreSeptember 18, 2024 | msn.comWhy ResMed's Rally Is Just Getting StartedSeptember 18, 2024 | seekingalpha.comStock Index Futures Tread Water With Fed Rate Decision in FocusSeptember 18, 2024 | msn.comResMed Faces Market Disruption and Limited Growth: A Sell Rating AnalysisSeptember 18, 2024 | markets.businessinsider.comWe Think ResMed (NYSE:RMD) Might Have The DNA Of A Multi-BaggerSeptember 18, 2024 | finance.yahoo.comResmed Inc at RBC Capital Markets Global Healthcare Conference TranscriptSeptember 14, 2024 | gurufocus.comResMed Inc at Morgan Stanley Global Healthcare Conference TranscriptSeptember 14, 2024 | gurufocus.com Get ResMed News Delivered to You Automatically Sign up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter. Email Address This Indicator called BOTH NVDA rallies (Ad)Rarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is… Click this link here. RMD Media Mentions By Week RMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RMD News Sentiment▼0.000.60▲Average Medical News Sentiment RMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RMD Articles This Week▼12▲RMD Articles Average Week Get ResMed News Delivered to You Automatically Sign up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alpha Tau Medical News Today Evome Medical Technologies News Today Fisher & Paykel Healthcare News Today Heart Test Laboratories News Today HeartBeam News Today Innovative Eyewear News Today Inspira Technologies Oxy B.H.N. News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:RMD) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ResMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ResMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
